Bohme 28 reported a percentage of responder patients of 34% for 35 μg/hour, 37% with for 52.5 μg/hour, and 50% for 70 μg/hour, but these response rates failed to reach statistical significance.
← all excerpts
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review.
1
—
—